Inogen, Inc. (INGN)
Stock Price:
$36.06 USD
0.59 (1.66%)
Updated November 23, 4:00 PM EST - Market closed
Key Info
| Market Cap |
797.56M |
| Revenue (ttm) |
313.43M |
| Net Income (ttm) |
-2.08M |
| Shares Out |
22.12M |
| EPS (ttm) |
-0.10 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 23 |
| Last Price |
$36.06 |
| Previous Close |
$35.47 |
| Change ($) |
0.59 |
| Change (%) |
1.66% |
| Day's Open |
35.47 |
| Day's Range |
34.50 - 36.85 |
| Day's Volume |
311,838 |
| 52-Week Range |
26.57 - 76.89 |
More Stats
| Market Cap |
797.56M |
| Enterprise Value |
587.51M |
| Earnings Date (est) |
Mar 2, 2021 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
22.12M |
| Float |
18.30M |
| EPS (basic) |
-0.09 |
| EPS (diluted) |
-0.10 |
| FCF / Share |
0.75 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
2.06% |
| Payout Ratio |
n/a |
| Shares Short |
2.09M |
| Short Ratio |
13.59 |
| Short % of Float |
11.41% |
| Beta |
0.89 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
48.63 |
| PS Ratio |
2.54 |
| PB Ratio |
2.09 |
| Revenue |
313.43M |
| Operating Income |
-11.82M |
| Net Income |
-2.08M |
| Free Cash Flow |
16.40M |
| Net Cash |
210.05M |
| Net Cash / Share |
9.50 |
| Gross Margin |
54.83% |
| Operating Margin |
-3.77% |
| Profit Margin |
-0.70% |
| FCF Margin |
5.23% |
| ROA |
-1.65% |
| ROE |
-0.60% |
| ROIC |
-4.40% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (6)
| Buy |
0 |
| Overweight |
0 |
| Hold |
5 |
| Underweight |
0 |
| Sell |
1 |
Price Target
$31.67*
(-12.17% downside)
Low
30.0
Current: $36.06
High
35.0
Target: 31.67
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Revenue | 362 | 358 | 249 | 203 | 159 | 113 | 75.44 | 48.58 | 30.63 |
| Revenue Growth | 1.07% | 43.57% | 22.98% | 27.56% | 41.29% | 49.17% | 55.31% | 58.57% | - |
| Gross Profit | 172 | 179 | 121 | 97.31 | 76.26 | 55.52 | 38.99 | 23.95 | 14.70 |
| Operating Income | 19.79 | 37.89 | 27.59 | 22.86 | 15.05 | 10.51 | 4.46 | 0.83 | -1.72 |
| Net Income | 20.95 | 51.85 | 21.00 | 20.52 | 11.59 | 6.83 | 25.44 | 0.56 | -2.00 |
| Shares Outstanding | 21.82 | 21.27 | 20.68 | 20.07 | 19.40 | 16.18 | 0.28 | 0.26 | 0.25 |
| Earnings Per Share | 0.94 | 2.30 | 0.96 | 0.97 | 0.56 | 0.30 | 0.68 | -19.97 | -20.15 |
| EPS Growth | -59.13% | 139.58% | -1.03% | 73.21% | 86.67% | -55.88% | - | - | - |
| Operating Cash Flow | 40.59 | 59.98 | 60.49 | 31.03 | 38.16 | 15.70 | 13.47 | 4.00 | 1.86 |
| Capital Expenditures | -6.51 | -12.97 | -10.23 | -8.02 | -12.49 | -16.24 | -18.14 | -12.45 | -8.96 |
| Free Cash Flow | 34.08 | 47.00 | 50.27 | 23.02 | 25.67 | -0.54 | -4.68 | -8.44 | -7.10 |
| Cash & Equivalents | 209 | 240 | 174 | 114 | 82.90 | 56.84 | 13.52 | 15.11 | - |
| Total Debt | 6.72 | - | - | - | 0.32 | 0.61 | 10.65 | 8.94 | - |
| Net Cash / Debt | 202 | 240 | 174 | 114 | 82.58 | 56.22 | 2.87 | 6.18 | - |
| Assets | 447 | 376 | 275 | 214 | 161 | 140 | 82.40 | 47.59 | - |
| Liabilities | 103 | 65.47 | 48.03 | 31.96 | 27.30 | 21.94 | 26.10 | 19.01 | - |
| Book Value | 345 | 310 | 227 | 182 | 134 | 118 | -62.37 | -80.77 | - |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Inogen, Inc. |
| Country |
United States |
| Employees |
1,020 |
| CEO |
Scott Wilkinson |
Stock Information
| Ticker Symbol |
INGN |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: INGN |
| IPO Date |
February 14, 2014 |
Description
Inogen, a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.